Unknown

Dataset Information

0

Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer.


ABSTRACT: Ovarian cancer is a highly aggressive disease and novel treatments are required. Thyroid hormones binding to ?v?3 integrin produced growth-promoting activities in ovarian cancer and we hypothesized that natural thyroid hormone derivatives may antagonize these actions. The effect of three antagonists, tetraiodoacetic acid (tetrac), triiodothyroacetic acid (triac) and 3-iodothyronamine (T1AM), on cell proliferation, cell death and DNA damage was studied in two ovarian cancer cell lines (OVCAR3 and A2780), normal hamster ovary control cells (CHOK1) and ?v?3-deficient or transfected HEK293 cells. A differential inhibition of cell proliferation was observed in ovarian cancer cells compared to CHOK1. In OVCAR3, an induction of cell cycle regulators was further shown. Apoptosis was confirmed (annexin-PI, SubG1/cell-cycle, apoptotic genes, caspase-3 and poly ADP ribose polymerase-1 (PARP-1) cleavage) and was reversed by a pan-caspase inhibitor. Induction in apoptosis inducing factor (AIF) was observed, suggesting a parallel caspase-independent mechanism. Integrin-involvement in triac/T1AM apoptotic action was shown in ?v?3-transfected HEK293 cells. Lastly, in ovarian cancer models, key proteins that coordinate recognition of DNA damage, ataxia-telangiectasia mutated (ATM) and PARP-1, were induced. To conclude, the cytotoxic potential of thyroid hormone derivatives, tetrac, triac and T1AM, in ovarian cancer may provide a much-needed novel therapeutic approach.

SUBMITTER: Shinderman-Maman E 

PROVIDER: S-EPMC5705594 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer.

Shinderman-Maman Elena E   Cohen Keren K   Moskovich Dotan D   Hercbergs Aleck A   Werner Haim H   Davis Paul J PJ   Ellis Martin M   Ashur-Fabian Osnat O  

Scientific reports 20171128 1


Ovarian cancer is a highly aggressive disease and novel treatments are required. Thyroid hormones binding to αvβ3 integrin produced growth-promoting activities in ovarian cancer and we hypothesized that natural thyroid hormone derivatives may antagonize these actions. The effect of three antagonists, tetraiodoacetic acid (tetrac), triiodothyroacetic acid (triac) and 3-iodothyronamine (T1AM), on cell proliferation, cell death and DNA damage was studied in two ovarian cancer cell lines (OVCAR3 and  ...[more]

Similar Datasets

| S-EPMC5292977 | biostudies-literature
| S-EPMC7355968 | biostudies-literature
| S-EPMC4453678 | biostudies-literature
| S-EPMC6168422 | biostudies-literature
| S-EPMC3541411 | biostudies-literature
| S-EPMC6995635 | biostudies-literature
| S-EPMC3656588 | biostudies-literature
| S-EPMC5507526 | biostudies-literature
| S-EPMC6089432 | biostudies-literature
| S-EPMC7144234 | biostudies-literature